Goldman Sachs analyst Chris Shibutani maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $51.00. The company's shares closed last Tuesday at $52.04. According to TipRanks.com, Shibutani is a 5-star analyst with an average return of 23.3% and a 48.8% success rate. Shibutani covers the Healthcare sector, focusing on stocks such as Amylyx Pharmaceuticals Inc, Arcutis Biotherapeutics, and Nektar Therapeutics. Pfizer has an analyst consensus of Moderate Buy, with a price target consensus of $57.08, implying an 8.3% upside from current levels. In a report issued on July 8, Morgan Stanley also maintained a Hold rating on the stock with a $49.
https://www.tipranks.com/news/blurbs/pfizer-pfe-receives-a-hold-from-goldman-sachs-2?utm_source=advfn.com&utm_medium=referral
Pfizer (NYSE:PFE)
過去 株価チャート
から 9 2022 まで 10 2022 Pfizerのチャートをもっと見るにはこちらをクリック
Pfizer (NYSE:PFE)
過去 株価チャート
から 10 2021 まで 10 2022 Pfizerのチャートをもっと見るにはこちらをクリック